Empowering Surgeons to Close with Confidence
The MOZART System is a major advancement in breast cancer margin assessment from KUBTEC. It uses 3D tomosynthesis X-ray technology, the gold standard for diagnostic mammography, to enable surgeons and radiologists to accurately detect positive margins in breast cancer patients undergoing segmental mastectomy.1
Benefits of The MOZART® System in the Operating Room
Re-excisions
In a UT Southwestern study of 446 breast cancer surgeries, The MOZART System "decreased re-excision rates by more than half" compared to the Hologic Trident® System.2
Tissue Preservation
In a MD Anderson study of 99 breast cancer surgeries the authors concluded that use of The MOZART System “decreases the amount of additional tissue excised unnecessarily."1
Efficiency
In a Rush Medical study, the use of The MOZART system “saved an average of 7.6 minutes per surgery and a decrease in OR cost of $284.62 per case” for wire‐localized segmental mastectomies.3
3 Dimensions
The MOZART System utilizes 3D tomosynthesis, which enables analysis in 1 millimeter digital slices. Each slice has its own margin, and can be viewed independently, unobscured by dense tissue above or below.
Features of The MOZART® System
Voice Control
Speech recognition technology allows you to operate the system without breaking scrub.
HD Optical Camera
Captures detailed optical images, enabling you to visually orient your specimen accurately, in real-time.
The Image Blender™
Combines optical and X-ray images for a most comprehensive view of the specimen’s anatomy.
Large Imaging Area
Large active imaging area for breast surgery and pathology specimens of all sizes.
Automatic Specimen Alert
Notifies you if a specimen is accidentally left inside the system.
Integrated with GammaPRO
Seamless use with GammaPRO® - Advanced crystal technology, a sleek design, and easy integration into OR workflows.
Image Gallery
The MOZART® System Image Gallery
Testimonials
"Three dimensional specimen tomosynthesis has brought specimen radiography in to the 21st century as it negates all the short comings of two dimensional radiography and accurately provides data for targeted re-excision of cavity margins thereby reducing total volume loss and enhancing aesthetics.”
Dr. Ashutosh Kothari
Oncoplastic & Reconstructive Breast Surgeon at Guy’s and St. Thomas NHS Foundation Trust
Clinical Data
Three-dimensional tomosynthesis intraoperative analysis of screen-detected breast malignancies reduces re-excision rates.
Royal Cornwall Hospital NHS Trust, Cornwall, England
View for View, 3-D Specimen Tomosynthesis Provides More Data Than 2-D Specimen Mammography
Studyfrom Department of Surgery, University of Washington, Seattle, Washington
Implementation of Intra-Operative Specimen Tomosynthesis and Impact of Re-Excision Rates for Image Guided Partial Mastectomies
Differences in Re-excision Rates for Breast-Conserving Surgery Using Intraoperative 2D Versus 3D Tomosynthesis Specimen Radiograph
Division of Surgical Oncology, Department of Surgery, The University of Texas Southwestern Medical Center, Dallas, TX
Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery
Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
The temporal and financial benefit of intraoperative breast specimen imaging: A pilot study of the Kubtec MOZART
Webinars
Get in touch
Contact us to see The MOZART System and its state-of-the-art, 3D margin assessment technology in action.
References
- Ko Un Park, MD, et al. Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery. Ann Surg Oncol 2019:26:1720-28.
- Natalia Partain, MD, et al. Differences in Re-excision Rates for Breast-Conserving Surgery Using Intraoperative 2D Versus 3D Tomosynthesis Specimen Radiograph. Ann Surg Oncol 2020: Published online Aug 01, 2020
- Hannah W. Kornfeld BA, et al. The temporal and financial benefit of intraoperative breast specimen imaging: A pilot study of the Kubtec MOZART. wileyonlinelibrary.com/journal/tbj Breast J. 2019;25:766–768